drugdeliverybusiness2d
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Medtronic expects pressure in surgical unit for fourth quarter, shares fall
Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...
Medtronic Falls 4.5% Pre-Market After Mixed Q3 Earnings, Full-Year Guidance Reaffirmed
Despite maintaining its full-year outlook, Medtronic slips in pre-market trading following a revenue miss in its Q3 report.
Medscape1d
Medtronic Warns About Insulin Pump Action During Air Travel
In an “urgent medical device correction,” the company urges clinicians to remind patients to monitor their glucose levels during takeoffs and landings.
Medtronic slips after reaffirming full-year guidance
Medtronic (MDT) stock slips as the company reaffirms full-year outlook after delivering mixed financial for Q3 fiscal 2025.
Medtronic’s stock drops on inventory hiccup and revenue miss
Medtronic PLC’s stock fell 7.3% as the worst performer in the S&P 500 on Tuesday after the medical-products company’s ...
MassDevice2d
Medtronic slightly misses on revenue in Q3
Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.
Medtronic Earnings Review: Stuck In The Single Digits Again
Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast
Medtronic Plc (NYSE:MDT) reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion. The ...